(Q39684373)

14 September 2017

Dual targeting of EphA2 and ER restores tamoxifen sensitivity in ER/EphA2-positive breast cancer. (English)

1 reference

14 September 2017

1 reference

8

1 reference

14 September 2017

9

Kathy D Miller

1 reference

14 September 2017

Yesim Gökmen-Polar

1

1 reference

14 September 2017

Rachel A Toroni

2

1 reference

14 September 2017

Barbara A Hocevar

3

1 reference

14 September 2017

Sunil Badve

4

1 reference

14 September 2017

Qianqian Zhao

5

1 reference

14 September 2017

Changyu Shen

6

1 reference

14 September 2017

Elizabeth Bruckheimer

7

1 reference

14 September 2017

language of work or name

English

0 references

publication date

3 July 2010

1 reference

Breast Cancer Research and Treatment

14 September 2017

1 reference

14 September 2017

127

1 reference

14 September 2017

375-384

1 reference

14 September 2017

2

1 reference

https://scigraph.springernature.com/pub.10.1007/s10549-010-1004-y

14 September 2017

0 references

cites work

Unified Nomenclature for Eph Family Receptors and Their Ligands, the Ephrins

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1004-Y

Eph-ephrin bidirectional signaling in physiology and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1004-Y

Eph receptors in breast cancer: roles in tumor promotion and tumor suppression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1004-Y

cDNA cloning and characterization of eck, an epithelial cell receptor protein-tyrosine kinase in the eph/elk family of protein kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1004-Y

The EphA2 receptor and ephrinA1 ligand in solid tumors: function and therapeutic targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1004-Y

Estrogen and Myc negatively regulate expression of the EphA2 tyrosine kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1004-Y

Prognostic breast cancer signature identified from 3D culture model accurately predicts clinical outcome across independent datasets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1004-Y

Gene expression signature in organized and growth-arrested mammary acini predicts good outcome in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1004-Y

Invasiveness of breast carcinoma cells and transcript profile: Eph receptors and ephrin ligands as molecular markers of potential diagnostic and prognostic application

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1004-Y

The receptor tyrosine kinase EphA2 promotes mammary adenocarcinoma tumorigenesis and metastatic progression in mice by amplifying ErbB2 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1004-Y

Significance analysis of microarrays applied to the ionizing radiation response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1004-Y

EphA2 reexpression prompts invasion of melanoma cells shifting from mesenchymal to amoeboid-like motility style

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1004-Y

Combinatorial control of gene expression by nuclear receptors and coregulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1004-Y

Coregulators in nuclear estrogen receptor action: from concept to therapeutic targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1004-Y

WNT signaling pathway and stem cell signaling network

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1004-Y

Wnt/beta-catenin signaling in development and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1004-Y

Alternative wnt signaling is initiated by distinct receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1004-Y

The Wnt signal transduction pathway in stem cells and cancer cells: influence on cellular invasion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1004-Y

Activation of EphA2 kinase suppresses integrin function and causes focal-adhesion-kinase dephosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1004-Y

Control of motile and invasive cell phenotypes by focal adhesion kinase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1004-Y

Wnt and calcium signaling: beta-catenin-independent pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1004-Y

Differential regulation of cell motility and invasion by FAK

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1004-Y

CD151 enhances cell motility and metastasis of cancer cells in the presence of focal adhesion kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1004-Y

Eph receptors and ephrin ligands: embryogenesis to tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1004-Y

Cross-talk between estrogen receptor and growth factor pathways as a molecular target for overcoming endocrine resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1004-Y

Diverse gene expression and DNA methylation profiles correlate with differential adaptation of breast cancer cells to the antiestrogens tamoxifen and fulvestrant

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1004-Y

Wnt/Planar cell polarity signaling: a new paradigm for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1004-Y

Wnt signaling pathways meet Rho GTPases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1004-Y

Overexpression and functional alterations of the EphA2 tyrosine kinase in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1004-Y

10.1007/S10549-010-1004-Y

21 January 2018

Identifiers

DOI

1 reference

14 September 2017

1 reference